Literature DB >> 12778750

[Preparation of cisplatin multivesicular liposomes and release of cisplatin from the liposomes in vitro].

Chao-ju Xiao1, Xian-rong Qi, Waer Aini, Shu-li Wei.   

Abstract

AIM: To prepare cisplatin multivesicular liposomes with high encapsulation efficiency and sustained-release character, and compare the release characteristics with conventional liposomes prepared by reverse-phase evaporation method.
METHODS: Cisplatin multivesicular liposomes were prepared using multiple emulsion method. The concentrations of cisplatin and lipids in the liposomes were measured by flameless atomic absorbance spectroscopy (FAAS) and phosphalipid enzyme reagent method, respectively. The encapsulation efficiency, size and release of the cisplatin from the liposomes were studied in vitro.
RESULTS: The mean diameter of cisplatin multivesicular liposomes was (16.6 +/- 1.0) micron. The encapsulation efficiency of cisplatin was more than 80%. The release profile in vitro fitted with a first-order equation. The releasing t1/2 of cisplatin multivesicular liposomes is 37.7 h, which is 8.4 that of conventional liposomes. Co-membrane stabilizer has remarkable stabilizing effect on the multivesicular liposomal membrane confirmed by differential scattering calorimetry (DSC).
CONCLUSION: The cisplatin multivesicular liposomes showed high encapsulation efficiency and sustained-release character.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12778750

Source DB:  PubMed          Journal:  Yao Xue Xue Bao        ISSN: 0513-4870


  2 in total

1.  Topical delivery and photodynamic evaluation of a multivesicular liposomal Rose Bengal.

Authors:  Maha Fadel M Ali
Journal:  Lasers Med Sci       Date:  2010-12-01       Impact factor: 3.161

2.  Design and development of multivesicular liposomal depot delivery system for controlled systemic delivery of acyclovir sodium.

Authors:  S K Jain; R K Jain; M K Chourasia; A K Jain; K B Chalasani; V Soni; A Jain
Journal:  AAPS PharmSciTech       Date:  2005-09-20       Impact factor: 3.246

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.